{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "WebPage",
      "@id": "https://iddi.com/resources/evaluating-the-potential-of-relapse-free-survival-as-a-surrogate-for-overall-survival-in-the-adjuvant-therapy-of-melanoma-with-checkpoint-inhibitors#WebPage",
      "url": "https://iddi.com/resources/evaluating-the-potential-of-relapse-free-survival-as-a-surrogate-for-overall-survival-in-the-adjuvant-therapy-of-melanoma-with-checkpoint-inhibitors",
      "name": "Evaluating The Potential of Relapse Free Survival as a Surrogate for Overall Survival in The Adjuvant Therapy of Melanoma with Checkpoint Inhibitors"
    },
    {
      "@type": "BreadcrumbList",
      "@id": "https://iddi.com/resources/evaluating-the-potential-of-relapse-free-survival-as-a-surrogate-for-overall-survival-in-the-adjuvant-therapy-of-melanoma-with-checkpoint-inhibitors#BreadcrumbList",
      "url": "https://iddi.com/resources/evaluating-the-potential-of-relapse-free-survival-as-a-surrogate-for-overall-survival-in-the-adjuvant-therapy-of-melanoma-with-checkpoint-inhibitors",
      "name": "Evaluating The Potential of Relapse Free Survival as a Surrogate for Overall Survival in The Adjuvant Therapy of Melanoma with Checkpoint Inhibitors"
    },
    {
      "@type": "WebSite",
      "@id": "https://iddi.com#WebSite",
      "url": "https://iddi.com",
      "name": "IDDI"
    },
    {
      "@type": "Organization",
      "@id": "https://iddi.com#Organization",
      "url": "https://iddi.com",
      "name": "IDDI"
    },
    {
      "@type": "Brand",
      "@id": "https://iddi.com#Brand",
      "url": "https://iddi.com",
      "name": "IDDI"
    },
    {
      "@type": "AggregateRating",
      "@id": "https://iddi.com#AggregateRating",
      "url": "https://iddi.com",
      "name": "IDDI"
    }
  ]
}